This contract award from the Defense Logistics Agency (DLA) is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of ZEPOSIA 0.92 MG CAPSULE 30S. The contract, valued at $13,862.79, is a Firm Fixed Price Delivery Order with a period of performance through December 23, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order is not designated with a set-aside requirement, indicating open competition. The contract supports the DLA's role in providing essential medical commodities, including specialty medications, to military treatment facilities, veterans' healthcare programs, and other federal medical institutions.
Generated 3/9/25, 1:02 AM